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Evidence from the pediatric traumatic brain injury and pediatric brain tumor 
populations suggests that positive family functioning serves as a protective factor for 
neurocognitive outcomes of children who survive these conditions. However, no research 
has been found that examines whether positive family functioning similarly moderates 
the effects of CNS-directed chemotherapy on the neurocognitive functioning of survivors 
of pediatric ALL. The purpose of this study is to examine the effect of family functioning 
upon neurocognitive outcome among survivors of pediatric ALL treated with 
chemotherapy. Based upon a multidimensional model of attention and Anderson’s model 
of executive function (EF), four subcomponents of attention (selective, divided, 
sustained, and shifting) and four subcomponents of EF (working memory, planning, 
inhibition, and processing speed) will be examined. Sequential, or hierarchical, multiple 
regression analyses will be conducted to examine the relationship between family 
functioning and neurocognitive functioning among survivors of pediatric ALL as well as 
a comparison group of healthy children. Data for the ALL group and the comparison 
group will be examined using separate analyses, with demographic and treatment-related 
variables entered first, followed by a family functioning variable. For the ALL group, 
 v 
 
family functioning is expected to explain a significant amount of variance in 
neurocognitive outcome, even after controlling for demographic and treatment-related 
variables. It is expected that this relationship will not be found for the comparison group. 
If so, this would have important implications for the survivors and their families. For 
example, survivors from families with lower levels of functioning could be identified 
early through screening measures and their families could receive targeted interventions 
aimed at improving family functioning and thus survivor outcomes. 
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Chapter One: Introduction 
The most common form of cancer among children and adolescents is Acute 
Lymphoblastic Leukemia (ALL; Bisen-Hersh, Hineline, & Walker, 2011). Due to 
improvements in treatment regimens over the past forty years, over 80% of children 
diagnosed with ALL now survive (Winick, 2011). However, it has been found that the 
various treatment methods used in treating ALL can lead to deficits in a variety of 
neurocognitive domains (Winick, 2011). Together, these deficits are known as 
“neurocognitive late effects” (Mulhern & Palmer, 2003). While the use of chemotherapy 
instead of radiation therapy has helped to decrease the neurocognitive late effects 
experienced by survivors of ALL, research has found that chemotherapy-only treatment 
can still cause subtle neurocognitive late effects (Anderson & Kunin-Batson, 2009). 
Specifically, the areas of attention, executive function, visual-processing, and visual-
motor integration have been found to be consistent areas of weakness among survivors of 
ALL treated with chemotherapy only (Buzier, de Sonneville, & Veerman, 2009). While 
these weaknesses are typically less pronounced than the weaknesses observed among 
survivors of ALL treated with radiation therapy, they still have important consequences 
for the survivors’ lives after cancer (Anderson & Kunin-Batson, 2009).  
 As researchers gain a better understanding of the neurocognitive late effects 
associated with chemotherapy-only protocols for the treatment of childhood ALL, 
emphasis in research is now shifting towards the identification of variables that may 
serve to moderate or protect against the neurocognitive late effects (Daly, Kral, & Brown, 
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2008; Mulhern & Palmer, 2003). Some have suggested that psychosocial variables such 
as family functioning may moderate neurocognitive outcome among survivors of 
pediatric cancer (Anderson & Kunin-Batson, 2009). 
In the field of traumatic brain injury, research suggests that the level of family 
functioning influences how well a child or adolescent recovers from neurocognitive insult 
(Max et al., 1999; Nadebaum, Anderson, & Catroppa, 2007; Taylor et al., 1999; Yeates et 
al., 1997). One study has investigated this phenomenon among survivors of pediatric 
brain tumors and found similar results (Carlson-Green, Morris, & Krawiecki, 1995). 
However, no research has been found that examines whether family functioning plays the 
same moderating role in the ALL population. The purpose of this study is to investigate 
whether family functioning moderates neurocognitive functioning following 
chemotherapy treatment for ALL. It is hypothesized that survivors of ALL from poorer 
functioning families will experience more severe neurocognitive late effects than those 
from higher functioning families.  
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Chapter Two: Integrative Analysis 
Acute Lymphoblastic Leukemia 
Prevalence. 
Childhood cancer, although relatively rare, is more common than many people 
realize and is a significant health problem around the world (Moore, 2005; Riccio, 
Sullivan, & Cohen, 2010). Approximately 1 out of every 300 children under the age of 16 
has cancer (Riccio et al., 2010). On average, one to two out of every 10,000 children is 
diagnosed with cancer each year in the United States (Moore, 2005; Butler & Haser, 
2006). For example, approximately 10,400 children under the age of 15 were diagnosed 
with cancer in the United States in 2007, and approximately 1,545 children died from the 
disease that year (Riccio et al., 2010). Cancer is the leading cause of death by disease 
among children under the age of 15 and the second leading cause of death among 
children and adolescents overall, with accidents the first (Moore, 2005; Riccio et al., 
2010).  
The incidence of childhood cancer varies by age and by type of cancer, with some 
cancers more common at certain ages than others (Riccio et al., 2010). In general, the 
types of cancer most often seen in children are quite different from those common among 
adults (Riccio et al., 2010). Types of cancer commonly seen in children and adolescents 
are “leukemias, brain and other nervous system tumors, lymphomas (lymph node 
cancers), bone cancers, soft tissue sarcomas, kidney cancers, eye cancers, and adrenal 
gland cancers (American Cancer Society [ACS], 2006)” (Riccio et al., 2010, p. 207), with 
leukemias and solid tumors most prevalent in this age group (Riccio et al., 2010). 
Leukemias are the most common form of cancer among children and adolescents, 
accounting for approximately one-third of cancers in children under the age of 15 and 
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one-fourth of cancers in people under the age of 20 (Butler & Haser, 2006; Riccio et al., 
2010; Bisen-Hersh et al., 2011). Leukemia refers to a diverse set of diseases of the blood 
forming tissues (Brown et al., 1992; Daly, et al., 2008; Riccio et al., 2010). Leukemia is 
characterized by the production of large amounts of abnormal early-stage white blood 
cells called leukocytes (Daly, et al., 2008; Riccio et al., 2010). The leukocytes block 
production of normal white blood cells and therefore impede the child’s ability to fight 
off infection (Daly, et al., 2008; Riccio et al., 2010). There are two types of normal white 
blood cells in which leukemia may develop: lymphoid cells and myeloid cells (U.S. 
Department of Health and Human Services, 2008). Leukemias that begin in lymphoid 
cells are referred to as lymphocytic, or lymphoblastic, leukemias; leukemias that begin in 
myeloid cells are referred to as myelogeneous, or myeloblastic, leukemias (U.S. 
Department of Health and Human Services, 2008). Leukemia can also be classified as 
either acute or chronic, depending on the speed with which the disease develops and 
progresses (U.S. Department of Health and Human Services, 2008). Acute leukemias are 
those that progress quickly, whereas chronic leukemias progress more slowly (U.S. 
Department of Health and Human Services, 2008).  Altogether, then, there are four main 
types of leukemia: acute lymphocytic leukemia, acute myelogenous leukemia, chronic 
lymphocytic leukemia, and chronic myelogenous leukemia (Riccio et al., 2010; U.S. 
Department of Health and Human Services, 2008). 
The most common form of leukemia among children is acute lymphocytic 
leukemia (ALL), which is also known as acute lymphoblastic leukemia (Butler & Haser, 
2006). ALL accounts for at least 75% of all cases of pediatric leukemia and 
approximately 25% of all childhood cancers overall (Butler & Haser, 2006; Mulhern & 
Butler, 2006; Riccio et al., 2010, Winick, 2011). This makes ALL the most common 
cancer of childhood and adolescence (Ashford et al., 2010; Kesler, Tanaka, & 
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Koovakkattu, 2010; Bisen-Hersh et al., 2011). Of the approximately 4,000 cases of ALL 
diagnosed annually in the United States, roughly two-thirds of these are among children 
and adolescents (Ashford et al., 2010). ALL occurs across ethnic groups but is slightly 
more prevalent among Caucasian children than among African American or Asian 
American children (Mulhern & Butler, 2006; Riccio et al., 2010). The yearly incidence of 
ALL among white children is about 3 or 4 per 100,000 (Mulhern & Palmer, 2003; 
Mennes et al., 2005). It is more common among boys than girls, with 1.3 males 
diagnosed for every 1 female diagnosed (McNeil, Cote, Clegg, & Mauer, 2002; Mulhern 
& Butler, 2006). The majority of cases of ALL are diagnosed in children between the 
ages of 2 to 5 years (Daly et al., 2008; Mulhern & Butler, 2006; Riccio et al., 2010). 
Characteristics of ALL. 
ALL is a “malignant disorder of lymphoid cells” that “results when a surplus of 
stem cells develop into lymphocytes, a type of white blood cell also referred to as 
leukemic cells” (Bisen-Hersh et al., 2011, p. 293). Lymphocytes are unable to fight 
infection and the proliferation of them leaves less room for healthy blood cells and 
platelets to form (Bisen-Hersh et al., 2011). The lymphocytes are originally found in the 
bone marrow (Mulhern & Butler, 2006). From there they enter the bloodstream and are 
transported, via the circulatory system, to nearly every organ system in the body (Bisen-
Hersh et al., 2011; Mulhern & Butler, 2006). This includes the central nervous system 
(CNS), which consists of the brain and the spinal cord (Carlson, 2010).  Possible genetic, 
environmental, and viral influences have been identified (Bisen-Hersh et al., 2011; 
Mulhern & Butler, 2006). For example, children with the genetic disorder Down 
syndrome have been found to be at an increased risk for the development of leukemia 
(Riccio et al., 2010). However, the genetic and environmental influences that have been 
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identified as implicated in the development of ALL so far do not account for the majority 
of cases of the disease and the exact causes of most cases of ALL remain unknown (Daly 
et al., 2008; Riccio et al., 2010; Bisen-Hersh et al., 2011). 
Presenting symptoms of ALL can include fever, fatigue, paleness of the skin, 
bone pain, easy bleeding or bruising, infection, swelling of the abdomen, swollen lymph 
nodes, enlargement of the thymus gland, headache, seizures, vomiting, rashes, gum 
problems, and/or weakness (Mulhern & Butler, 2006; Riccio et al., 2010). Since many of 
these symptoms resemble those of a number of nonmalignant conditions, definitive 
diagnosis is based upon a combination of laboratory tests and imaging results and is 
sometimes delayed (Mulhern & Butler, 2006; Riccio et al., 2010). The specific laboratory 
tests used to diagnosis ALL include blood smear, bone marrow aspiration, bone marrow 
biopsy, spinal tap, and lymph node biopsy, with bone marrow aspiration being the most 
commonly used diagnostic test for this condition (Mulhern & Butler, 2006; Riccio et al., 
2010). Once a child is diagnosed with ALL they are classified into one of four categories 
based upon the progression of the disease: low-risk, standard-risk, high-risk, and very 
high-risk (Riccio et al., 2010). This classification is made based upon the presence of 
cancer cells beyond the bone marrow and blood, in organs such as the liver, spleen, or 
lymph nodes (Riccio et al., 2010). 
Treatment for ALL. 
Treatment for ALL generally lasts for two to three years and consists of multiple 
phases (Bisen-Hersh et al., 2011; Moleski, 2000; Butler & Haser, 2006). Prior to the early 
1960s, survival rates for ALL were very low (Moleski, 2000; Moore, 2005). However, 
survival rates have improved dramatically since that time due to marked improvements in 
the treatment of ALL (Butler & Haser, 2006; Winick, 2011). The factor most commonly 
credited as responsible for decreased mortality rates of ALL over the past several decades 
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has been the introduction of prophylactic CNS treatment, which prevents leukemia from 
spreading into the CNS (Buizer et al., 2009; Hill, Ciesielski, Sethre-Hofstad, Duncan, & 
Lorenzi, 1997; Von der Weid et al., 2003). CNS prophylaxis is necessary because the 
blood-brain barrier prevents chemotherapeutic agents delivered to the rest of the body 
from reaching the CNS (Buizer et al., 2009; Moleski, 2000). Without CNS prophylaxis 
the CNS is a sanctuary for leukemic cells and the chance of CNS relapse is high (Butler 
& Haser, 2006; Mennes et al., 2005; Mulhern & Palmer, 2003). CNS relapse, also known 
as CNS leukemia, occurs when leukemic cells invade and proliferate within the CNS 
(Brown et al., 1992; Moleski, 2000). Without CNS prophylaxis up to 80% of children and 
adolescents with ALL experience CNS relapse (Buizer et al., 2009). CNS relapse is a 
major cause of mortality in ALL (Buizer et al., 2009). The best way to treat CNS relapse 
is to prevent it from occurring, so CNS prophylaxis has become a standard part of 
treatment for children with ALL (Brown et al., 1992; Iuvone et al., 2002).  
These new treatment protocols have served to nearly eliminate the occurrence of 
CNS relapse, which now occurs in less than 10% of cases of ALL (Buizer et al., 2009; 
Moleski, 2000). Currently, approximately 80% of children and adolescents diagnosed 
with ALL reach long-term event-free survivorship (Jansen et al., 2008; Waber et al., 
2011). Survival rates are expected to rise to 90% in the next decade (Ashford et al., 2010; 
Bishen-Hersh et al., 2011). 
Late effects of treatment. 
With the increased survival rates that have accompanied improvements in the 
treatment of childhood ALL in the past several decades, interest has grown in the study of 
the “late effects” of CNS prophylactic treatment (Bisen-Hersh et al., 2011; Brouwers, 
2005). Late effects are impairments in functioning that occur after the successful 
completion of cancer therapy (Mulhern & Butler, 2006). They are generally defined as 
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occurring two or more years after the time of diagnosis and are thus different from “acute 
effects”, the “effects of disease and treatment that are acute or subacute and time limited, 
such as chemotherapy-induced nausea and vomiting or temporary cognitive changes 
induced by cancer therapy” (Mulhern & Butler, 2006, p. 262). Late effects are generally 
considered to be chronic and progressive (Mulhern & Butler, 2006). Among survivors of 
childhood cancer overall, approximately two-thirds experience at least one long-term 
consequence, or late effect, from their cancer and its treatment (Nathan et al., 2007). 
Survivors of childhood ALL are especially at risk for long-term and progressive 
impairment in the area of cognitive functioning because CNS prophylaxis treatment can 
be toxic to the developing brain (Kesler et al., 2010; Nathan et al., 2007). The 
intellectual, academic, and neuropsychological deficits caused by CNS prophylactic 
treatment are known collectively as “neurocognitive late effects” (Daly et al., 2008; Espy 
et al., 2001).  
The first form of CNS prophylactic treatment for ALL, introduced in the late 
1960s and early 1970s, was cranial irradiation or cranial radiation therapy (CRT; Buizer 
et al., 2009; Montour-Proulx et al., 2005). At first, CRT consisted of 24 Gy of radiation 
delivered to the spinal cord (Buizer et al., 2009; Von der Weid et al., 2003). Although it 
served to significantly decrease the incidence of CNS relapse, and thus increased survival 
rates among children with ALL, research found a high incidence of neurocognitive 
deficits among survivors of ALL treated with CRT (Brown et al., 1992; Montour-Proulx 
et al., 2005). These included significant declines in overall intellectual functioning as 
well as impairments in short-term memory, attention, information processing, motor 
speed, and perception (Brown et al., 1992; Moleski, 2000). Furthermore, survivors of 
ALL treated with CRT were found to have an increased incidence of special education 
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placements for learning disabilities and to have decreased rates of secondary school 
completion (Mennes et al., 2005). 
Based upon this research into the late effects of CRT, pediatric oncologists then 
began to explore ways to decrease the amount of CRT administered to children with 
ALL, while still ensuring survival. They began reducing the dosage of CRT (to 18 or 
even 12 Gy) and adding chemotherapy to the treatment protocols for childhood ALL 
(Buizer et al., 2009; Montour-Proulx et al., 2005). The chemotherapy was delivered 
intrathecally (directly into the spinal fluid) and typically consisted of the drug 
methotrexate (MTX), alone or in combination with other drugs (Brown et al., 1998; 
Buizer et al., 2009; Mulhern & Palmer, 2003). It was found that level of radiation could 
be reduced without negatively impacting CNS relapse-free survival rates, and a 
combination of CRT and intrathecal (IT) chemotherapy was the primary form of CNS 
prophylaxis for childhood ALL in the 1970s and early 1980s (Buizer et al., 2009; Kingma 
et al., 2002; Von der Weid et al., 2003). However, a high incidence of neurocognitive late 
effects persisted among survivors treated with combined modality (chemotherapy plus 
CRT) therapy, despite the decreased levels of radiation that were involved (Buizer et al., 
2009; Kingma et al., 2002; Montour-Proulx et al., 2005). 
In the mid-1980s, CRT was eliminated and chemotherapy-only treatment 
protocols began to be used as CNS prophylaxis for non-high-risk childhood ALL (Hill et 
al., 1997; Jansen et al., 2008; Kingma et al., 2002). It was found that similar, or even 
better, survival rates could be generated with chemotherapy-only treatment among 
children with standard-risk ALL (Buzier, de Sonneville, van den Heuvel-Eibrink, & 
Veerman, 2005; Moleski, 2000; Von der Weid et al., 2003). Currently, CRT is only used 
with children who are deemed to be at the highest risk for CNS disease, those who have 
CNS disease at the time of diagnosis, and those who experience CNS relapse (Kingma, et 
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al., 2002; Espy et al., 2001; Moleski, 2000). Typical CNS prophylaxis for non-high risk 
ALL now consists of systemic and IT chemotherapy, with or without intravenous MTX 
as well (Iuvone et al., 2002; Kingma et al., 2002; Montour-Proulx et al., 2005). Recent 
research has suggested that CRT may also be safely eliminated from treatment protocols 
for high-risk patients (Buizer et al., 2009). The specific chemotherapeutic agents used 
vary across medical institutions, but IT chemotherapy typically consists of MTX, alone or 
in combination with other drugs such as cytosine arabinoside (bytarabine), anthracyclines 
(such as doxorubicin), asparaginase, mercapclines, vincristine, and corticosteroids 
(Bisen-Hersh et al., 2011; Moleski, 2000).  
Neurocognitive Late Effects of Chemotherapy 
Given that chemotherapy-only protocols are now the standard form of CNS 
prophylaxis for the majority of children and adolescents with ALL, research interest in 
the neurocognitive late effects of this form of treatment has grown immensely over the 
past few decades (Buizer et al., 2009; Butler & Haser, 2006). Although there has been 
some inconsistency among the results of studies in this area, methodologically sound 
studies on the intellectual, academic, and neuropsychological functioning of ALL 
survivors treated with chemotherapy for CNS prophylaxis have shown that a significant 
amount of survivors show evidence of deficits in at least one area of functioning 
(Moleski, 2000; Peterson et al., 2008). 
Intellectual functioning. 
In terms of intellectual functioning, studies have found that survivors of childhood 
ALL treated with chemotherapy demonstrate impaired performance on measures of Full 
Scale IQ (FSIQ; Giralt et al., 1992; Hill et al., 1997; Raymond-Speden, Tripp, Lawrence, 
& Holdaway, 2000), Verbal IQ (VIQ; Giralt et al., 1992; Harila, Winqvist, Lanning, 
Bloigu, & Harila-Saari, 2009; Hill et al., 1997; Kingma et al., 2002; Raymond-Speden et 
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al., 2000), Performance IQ (PIQ; Brown et al., 1998; Giralt et al., 1992; Harila et al., 
2009; Hill et al., 1997; Raymond-Speden et al., 2000), and Simultaneous Processing 
(Brown et al., 1992). Furthermore, some studies have found that children and adolescents 
receiving chemotherapy for CNS prophylaxis in ALL show evidence of declines in 
various areas of intellectual functioning over time after their treatment has ended. These 
areas include FSIQ (Mulhern, Fairclough, & Ochs, 1991; Ochs et al., 1991), VIQ (Harila 
et al., 2009; Mulhern et al., 1991; Ochs et al., 1991), and PIQ (Jansen et al., 2006; 
Montour-Proulx et al., 2005; Mulhern et al., 1991). However, other studies have found 
ALL survivors treated with chemotherapy-only to perform similarly to controls on 
measures of intellectual functioning (Anderson, Godber, Smibert, Weiskop, & Ekert, 
2000; Ashford et al., 2010; Kingma et al., 2001; Rowland et al., 1984; Stehbens et al., 
1994; Tamaroff et al., 1982; Ueberall et al., 1996; Von der Weid et al., 2003; Waber et 
al., 1995). Other studies found deficits in intellectual functioning relative to controls that 
approached, but did not reach, statistical significance (Carey et al., 2008; Kaemingk, 
Carey, Moore, Herzer, & Hutter, 2004; Reddick et al, 2006; Schatz, Kramer, Ablin, & 
Matthay, 2000).  
In order to resolve these contradictions as to the presence or absence of deficits in 
intellectual functioning among ALL survivors treated with chemotherapy-only protocols, 
Moleski conducted an extensive review of the literature in 2000. Reviewing 33 studies 
published between 1981 and 1997, Moleski found that roughly two-thirds of the studies 
reported deficits in at least one area of intellectual functioning. Many of the studies that 
did not report finding evidence of impaired intellectual functioning among this 
population had significant methodological weaknesses (Moleski, 2000). In some of the 
studies, researchers reported that chemotherapy alone was not neurotoxic because the 
patients’ mean IQ was in the average range. However, this conclusion is problematic 
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because research has found that healthy siblings of ALL survivors tend to function in the 
above average range of intellectual functioning, with an average IQ value of 
approximately 112 to 113 (Moleski, 2000). Therefore, it is reasonable to assume that the 
survivors themselves may have been functioning in the above average range as well if not 
for their treatment, and IQ scores in the lower end of the average range may in fact 
represent a decline in functioning for this population. Because of this, scholars have 
argued that is important to use matched controls, as opposed to normative data, for 
comparison when investigating neurocognitive late effects in this population (Moleski, 
2000).  
Some studies included in Moleski’s seminal review of the literature enlisted a 
non-CNS treated cancer group in order to control for school absences due to treatment as 
well as for the psychological experience of having cancer (Moleski, 2000). All but one of 
these studies found evidence of impaired intellectual functioning among ALL patients 
receiving IT chemotherapy for CNS prophylaxis. Other studies used a healthy non-sibling 
control group for comparative purposes (Moleski, 2000).  Two of these studies did not 
find evidence of declines in intellectual functioning among the subjects who had received 
chemotherapy. However, these two articles, which report on results from the same larger 
study, included both CNS- and non-CNS-treated cancer patients in their “chemotherapy-
only” group. Therefore, no conclusions about the effects of chemotherapy used for CNS 
prophylaxis can be made, as the CNS-treated subjects were mixed with what should have 
been a non-CNS cancer control group. Another study that reported finding no evidence of 
declines in intellectual functioning among ALL survivors treated with chemotherapy had 
only 3 such subjects in its study (Moleski, 2000), a sample size that makes rendering 
conclusions for the larger population rather difficult. Overall, Moleski found that studies 
which had included a control group of either siblings or non-CNS-treated cancer patients 
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consistently found significant differences in intellectual functioning between the control 
groups and ALL survivors treated with chemotherapy.  
Peterson and colleagues followed up Moleski’s review of the literature with a 
meta-analysis in 2008. Criteria used for inclusion in the meta-analysis were: inclusion of 
participants who had competed chemotherapy-only treatment for pediatric ALL as well 
as a comparison group that did not receive CNS-directed treatment, publication in 
English, inclusion of enough original data to allow for calculation of effect sizes, and 
publication after 1990 (Peterson et al., 2008). Of the 160 relevant articles originally 
found, the majority failed to meet criteria for inclusion in the study and only 13 were 
included in the meta-analysis. The results of the analysis indicated that survivors of 
pediatric ALL treated with chemotherapy alone had significantly lower FSIQ scores as 
compared to control groups (Mean effect size = 0.55, 95% Confidence Interval = 0.27 – 
0.83, n = 10). After eliminating from analysis the three studies that had used test norms as 
the control group and the three that utilized foreign translations of intelligence tests, the 
recalculated mean effect size for FSIQ from the remaining seven studies was still 
significantly different from zero (M = 0.76, 95% CI = 0.42 – 1.12, n = 7). Similar results 
were found for the index scores VIQ and PIQ and for subtests measuring working 
memory and processing speed as well. These results provide empirical support to the 
assertion that survivors of pediatric ALL treated with chemotherapy-only do experience 
deficits in intellectual functioning following their treatment. 
Neuropsychological functioning. 
Deficits in intellectual and academic functioning among this population have been 
well established in the literature (Mulhern & Palmer, 2003). Originally, it was thought 
that these deficits could be due to the general effects of chronic illness and school 
absenteeism (Mulhern & Palmer, 2003). However, studies involving control groups 
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comprised of pediatric cancer patients whose treatment did not include CNS directed 
chemotherapy have disproved this notion (Mulhern & Palmer, 2003). It is now believed 
that deficits in intellectual and academic functioning are “secondary” late effects 
resulting from deficits in what are called “core” areas of neuropsychological functioning, 
such as attention, working memory, processing speed, and memory (Bisen-Hersh et al., 
2011; Schatz et al., 2000). It is thought that these deficits in core mental processes impair 
the development of higher-level abilities, leading to the declines in IQ level found among 
this population (Bisen-Hersh et al., 2011; Schatz et al., 2000).  
The focus of research on neurocognitive late effects of chemotherapy among 
survivors of childhood ALL has shifted from the study of global intellectual functioning 
to the identification of patterns of specific neuropsychological deficits in this population 
(Butler & Haser, 2006; Moleski, 2000; Mulhern & Palmer, 2003). Evidence from these 
studies has shown that survivors of childhood ALL treated with chemotherapy alone 
consistently show declines in at least one area of “core” neuropsychological functioning 
(Moleski, 2000). The specific core neuropsychological domains most commonly affected 
in this population are attention and executive functioning (Anderson & Kunin-Batson, 
2009; Buizer et al., 2009; Peterson et al., 2008). These basic neuropsychological 
processes are crucial for the acquisition of new information and skills, and deficits in 
these areas are thought to underlie poor performance of ALL survivors in the classroom 
and beyond (Buizer et al., 2009; Mulhern & Palmer, 2003). 
Attention. 
The domain of attention consists of a number of subdomains, including selective 
attention, divided attention, sustained attention, and shifting attention (Baron, 2004; 
Ginstfeldt & Emanuelson, 2010; Mirsky, Anthony, Duncan, Ahearn, & Kellam, 1991). 
Selective attention is the ability to maintain focus on a particular cognitive set or stimuli 
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“in the presence of background ‘noise’ or distraction” (Baron, 2004, p. 222). Commonly 
used tests of selective attention include digit span tasks, where participants are asked to 
repeat a sequence of numbers read to them by the examiner. Divided attention is the 
ability to “respond to more than one task or event simultaneously” (Baron, 2004, p. 222). 
Commonly administered tests of divided attention include trail making tests, in which the 
participant has to draw a line between circles while alternating between numbers and 
letters in sequence. Sustained attention is defined as the “ability to maintain vigilance and 
respond consistently during continuous or repetitive activity” (Baron, 2004, p. 223). 
Commonly administered tests of sustained attention include continuous performance 
tests, which require the subject to attend to a visual or auditory presentation of a series of 
random letters and to respond to a target stimulus. Finally, shifting attention is the ability 
to flexibly shift ones attention from one focus or stimuli to another (Baron, 2004). 
Commonly administered tests of shifting attention include verbal and design fluency 
tests, which detect difficulties with the ability to shift in terms of perseverative errors 
(Baron, 2004).  
Survivors of ALL treated with chemotherapy alone have been found to 
demonstrate impairments in a variety of subdomains of attention. In fact, attention is one 
of the domains most commonly found to be impacted in studies of this population, with 
approximately one-fourth of survivors of ALL showing evidence of deficits in attention 
(Bisen-Hersh et al., 2011; Butler & Copeland, 2002). Specifically, studies have found 
evidence of impaired performance, relative to controls, on tests of selective (Ashford et 
al., 2010; Carey et al., 2008; Harila et al., 2009), divided (Carey et al., 2008; Kingma et 
al., 2002; Lesnik, Ciesielski, Hart, Benzel, & Sanders, 1998), sustained (Reddick et al., 
2006), and shifting (Buizer et al., 2005) attention. These deficits may impact survivors’ 
ability to maintain concentration and ignore distractions, which in turn may negatively 
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impact their academic achievement and quality of life (Anderson & Kunin-Batson, 2009; 
Butler & Copeland, 2002).  
Executive functioning. 
Executive functioning (EF) is a somewhat nebulous concept within the field of 
neuropsychology, as several differing definitions and models of EF have been proposed 
but none have received universal acceptance (Baron, 2004). Various subcomponents of 
EF that have been proposed include planning, reasoning, cognitive flexibility, inhibition, 
initiation, and working memory (Anderson, 2002; Baron, 2004). Further complicating the 
conceptualization and assessment of EF is the fact that various aspects of EF overlap 
considerably with other domains of neurocognitive functioning such as attention and 
memory (Baron, 2004). However, the abilities that fall under the domain of EF are 
crucial to successful daily living and consideration of their intactness among survivors of 
pediatric ALL is critical (Anderson, 2002; Baron, 2004). 
Researchers have proposed a developmental model of executive functioning 
based upon factor analysis and clinical neuropsychological knowledge (Anderson, 2002). 
In this model, EF is comprised of four distinct domains, referred to as: (a) attentional 
control, (b) information processing, (c) cognitive flexibility, and (d) goal setting. 
Although these domains are thought to be separate within this model, they are also 
thought to operate in an integrative manner in order to execute tasks. Thus, they can be 
conceptualized of as an overall control system (Anderson, 2002). Each of these domains 
subsumes a number of highly integrated cognitive processes. 
Within this model of EF, the attentional control domain relates to the ability to 
selectively attend to certain stimuli, to inhibit certain responses, and to focus attention for 
a prolonged period of time (Anderson, 2002). Therefore, it consists of processes such as 
selective attention, self-regulation, self-monitoring, and inhibition. Deficits in attentional 
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control are thought to be reflected by impulsive behavior, lack of self-control, failure to 
complete tasks, the inability to self-correct procedural mistakes, and inappropriate 
responses to stimuli or situation. 
The information processing domain refers to the ability to quickly and accurately 
process information (Anderson, 2002). It is thought to include processes such as 
efficiency, fluency, and processing speed. Deficits in this domain are thought to be 
reflected by reduced output, delayed responses, hesitancy, and slow reaction times. 
The goal setting domain refers to the ability to develop new initiatives and 
concepts, to plan actions in advance, and to approach tasks in an efficient and strategic 
manner (Anderson, 2002). Aspects of this domain include initiative, conceptual 
reasoning, planning, and strategic organization. Deficits in this domain are reflected by 
poor problem solving abilities, disorganization, poor planning, development of inefficient 
strategies, continued reliance on previously learned strategies even when they are no 
longer effective, and poor conceptual reasoning.  
The cognitive flexibility domain refers to the ability to shift between cognitive 
sets, to learn from mistakes, to divide attention, to devise alternative strategies, and to 
simultaneously process multiple sources of information (Anderson, 2002). Components 
of this domain are divided attention, working memory, conceptual transfer, and feedback 
utilization. Deficits in this domain are reflected in rigidity and ritualistic behavior, 
difficulty with new activities or procedures, failure to adapt to new demands, and 
perseverative behavior such as continuing to make the same mistake or break the same 
rule regardless of feedback. 
Studies have found that survivors of pediatric ALL treated with chemotherapy-
only show evidence of deficits, relative to controls, in various aspects of executive 
functioning. These include cognitive flexibility/working memory (Ashford et al., 2010; 
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Carey et al., 2008; Kingma et al., 2002; Lesnik et al., 1998; Waber et al., 1995), 
information processing/processing speed (Jansen, 2008), and attentional 
control/inhibition (Harila et al., 2009). These deficits have been found to underline 
problems with behavior and school performance among survivors of ALL treated with 
chemotherapy-only protocols (Buizer et al., 2009). Furthermore, deficits in executive 
functioning have implications for survivors’ long-term occupational and social 
functioning and their overall quality of life (Campbell et al., 2007). 
Summary.  
Overall, research shows that chemotherapy-only treatment for ALL, while 
perhaps less neurotoxic than CRT, is still associated with neurocognitive late effects 
(Riccio et al., 2010; Winick, 2011). Deficits in the areas of attention and executive 
functioning are particularly prevalent among this population (Anderson & Kunin-Batson, 
2009; Campbell et al., 2007; Peterson et al., 2008; Riccio et al., 2010; Winick, 2011). 
These deficits may lead to real and significant impairments in the classroom setting 
(Nathan et al., 2007). Impairments in attention and executive functions such as working 
memory, cognitive flexibility, and inhibition have also been found to be associated with 
increased stress and problem behavior and decreased ability to use effective coping 
strategies among survivors of pediatric ALL, all of which impact the survivors’ quality of 
life (Riccio et al., 2010). 
Risk and protective factors. 
As understanding of the neurocognitive late effects of chemotherapy-only 
treatment for ALL improves, a prominent focus of research has become the risk and 
protective factors that serve to mediate and moderate the effects of the treatment. 
Traditionally the focus of this research has been on biologic moderators and mediators, 
including disease and treatment-related factors such as the intensity of the treatment 
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regimen (Brouwers, 2005; Buizer et al., 2009). Children who have received intensified 
treatment, such as higher doses of systemic methotrexate, have been found to perform 
significantly worse than survivors treated on lower intensity protocols in a few studies 
(Buizer et al., 2005; Buizer et al., 2009). However, some studies examining differences in 
outcome based on risk-group and treatment intensity have found that these differences are 
less pronounced than those related to child characteristics such as age at diagnosis and 
maternal education level (Waber et al., 2011). Such findings suggest that a focus on 
child-related and psychosocial risk factors is increasingly important for this population.  
Child-related moderators of neurocognitive outcome include age at diagnosis, 
gender, time since diagnosis, and age at testing (Brouwers, 2008). Specifically, young 
age at diagnosis and female gender have been found to be risk factors for neurocognitive 
late effects following chemotherapy-only treatment for ALL (Buizer et al., 2009; 
Moleski, 2000; Peterson et al., 2008). Particularly, children younger than 5 years of age 
at the time of diagnosis have been found to be particularly vulnerable to cognitive 
dysfunction as a result of their treatment (Buizer et al., 2009). This is believed to be due 
to the fact that their brains, being less mature than those of older children, are more 
vulnerable to the neurotoxicity of the treatments used for CNS prophylaxis (Buizer et al., 
2009). In this case, age at treatment is seen as a proxy for the level of 
“neurodevelopmental maturity” of the child’s brain (Mulhern & Palmer, 2003). Several 
studies have found that male survivors of pediatric ALL outperform female survivors on 
tests of neurocognitive functioning (Buizer et al., 2009). Effect-size statistics used in a 
meta-analysis on this literature confirmed the significance of the differential 
performances between male and female survivors (Peterson et al., 2008). Thus, girls 
appear to exhibit more late effects.  
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In addition to these child-related moderators, social and demographic moderators 
of neurocognitive outcome in this population have also been identified. Socioeconomic 
status (SES) has been identified as one such moderator in that differences in SES have 
been found to account for a significant amount of variability in neurocognitive outcome 
among this population (Stehbens et al 1994; Winick, 2011). Specifically, survivors of 
pediatric cancer from families with higher levels of SES have been found to have higher 
levels of neurocognitive functioning after treatment (Mulhern & Palmer, 2003). 
Research has clarified our understanding of the medical, treatment-related, child-
related, and demographic factors that mediate and moderate neurocognitive outcome in 
survivors of pediatric ALL (Patel & Carlson-Green, 2005). However, much less is known 
about potential psychosocial moderators of neurocognitive outcome in this population 
(Anderson & Kunin-Batson, 2009). One specific potential psychosocial moderator of 
neurocognitive outcome that has not yet been explored among survivors of pediatric ALL 
is that of family functioning. Given evidence from the pediatric traumatic brain injury 
and pediatric brain tumor fields as to the effect that family variables have on 
neurocognitive outcome, it is worth exploring whether positive family functioning serves 
as a protective factor against neurocognitive late effects for survivors of pediatric ALL 
(Anderson & Kunin-Batson, 2009; Hocking et al., 2011; Nathan et al., 2007).  
Family Functioning 
From a family systems perspective, family functioning refers to a family’s ability 
to engage in basic interactional patterns that enable them to achieve family goals (Walsh, 
2011). There are several models of family functioning, but most include dimensions such 
as “family structure or organization, communication, cohesion, problem solving, and 
emotional expression” (Hocking et al., 2011, p. 945). One model of family functioning 
that is used quite often in research and practice is the McMaster Model of Family 
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Functioning (MMFF), which was first described by Epstein, Bishop, and Levin in 1978 
(Carlson, 2003; Epstein, Ryan, Bishop, Miller, & Keitner, 2003). 
The McMaster Model of Family Functioning. 
Grounded in systems theory, the MMFF views families as open systems that are 
comprised of various subsystems (i.e., parents, children) that relate to other, larger 
systems such as schools and extended family (Carlson, 2001; Epstein et al., 2003; Lebow 
& Stroud, 2011). Underlying the MMFF is the assumption that the primary purpose of 
the family unit is to facilitate the social, psychological, and biological growth and 
maintenance of its members (Epstein et al., 2003). According to this model, this purpose 
is achieved through the accomplishment of a variety of tasks, which the developers of the 
MMFF divide into three types: Basic Tasks, Developmental Tasks, and Hazardous Tasks 
(Epstein et al., 2003; Lebow & Stroud, 2011). Basic Tasks are the most fundamental and 
involve instrumental issues such as the provision of food, money, transportation, and 
shelter (Epstein et al., 2003). Developmental Tasks are the various stages that the family 
and its members face over time. These occur on both an individual level (i.e., infancy, 
childhood, adolescence, middle age, and old age) and a family level (i.e., the beginning of 
a marriage, a first pregnancy, or the “empty nest” after the last child leaves home; Epstein 
et al., 2003). Hazardous Tasks are crises that arise due to unexpected circumstances, such 
as accidents or job loss (Epstein et al., 2003). Inability for a family to effectively 
accomplish these three task areas has been found to be associated with the development 
of clinically significant problems and maladaptive family functioning (Epstein et al., 
2003). 
Dimensions of family functioning in the MMFF. 
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The MMFF identifies six dimensions of family functioning as being most 
important for the emotional and physical health of family members and the effective 
accomplishment of the tasks required of the family (Epstein et al., 2003; Lebow & 
Stroud, 2011). The six dimensions, which will be defined in greater detail, are: problem 
solving, communication, role functioning, affective responsiveness, affective 
involvement, and behavior control (Epstein et al., 2003; Lebow & Stroud, 2011). Within 
each dimension, the authors of the MMFF have identified practices and patterns of 
interaction that they deem to range from “most ineffective” to “most effective” (Epstein 
et al., 2003). “Most ineffective” functioning in a dimension is thought to lead to the 
development of clinically significant difficulties for the family, while “most effective” 
functioning in all dimensions is thought to contribute to “optimal physical and emotional 
health” among family members (Epstein et al., 2003, p. 582). Research on the MMFF has 
not found one dimension that serves to predict good or poor overall family functioning on 
its own; rather, all dimensions are thought to be important to understanding the overall 
function of a family (Epstein et al., 2003). 
Problem solving. 
Problem solving is defined within this model as the ability of a family to 
efficiently and easily resolve problems so as to maintain effective family functioning 
(Epstein et al., 2003; Lebow & Stroud, 2011; Miller et al., 2000). The MMFF identifies 
two types of problems that families face: instrumental and affective (Epstein et al., 2003). 
Instrumental problems are those that relate to the provision of basic necessities of living, 
whereas affective problems are those relating to emotions and feelings (Epstein et al., 
2003).  
In the MMFF, effective problem solving can be broken down into seven 
sequential steps: (1) problem identification, (2) communication about the problem with 
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appropriate people, (3) development of a set of possible solutions, (4) deciding which 
solution to pursue, (5) putting the solution into place, (6) monitoring the progress of 
solution implementation, and (7) evaluation of the effectiveness of the problem-solving 
process (Epstein et al., 2003). According to this theory, the process that a family engages 
in when faced with problems in need of solutions is more important than the content of 
those problems in determining the level of functioning of the family (Epstein et al., 
2003). Highly functioning families tend to engage in these steps (discussing the issues, 
communicating with each other, deciding on and implementing an appropriate solution, 
etc.) whether the problem is relatively minor or is rather major, such as a job loss or 
terminal illness (Epstein et al., 2003).  
The developers of the MMFF hypothesize that most effective functioning in this 
domain occurs when (a) both instrumental and affective problems are solved and (b) 
when all seven steps of the problem-solving process are preformed (Epstein et al., 2003). 
Least effective functioning is thought to occur when families are unable to complete even 
step one of the process, the identification of problems (Epstein et al., 2003). 
Communication. 
The second dimension of family functioning included in the MMFF is 
communication, which is defined within the model as the patterns of verbal information 
exchange that occur within the family (Epstein et al., 2003; Lebow & Stroud, 2011; 
Miller et al., 2000). The MMFF focuses on verbal, as opposed to nonverbal or behavioral, 
communication because it is more easily observed and measured (Epstein et al., 2003). 
Furthermore, it focuses on the overall family pattern of communication as opposed to 
examining the individual communication styles of members of the family, as this has 
been found to be most helpful to families and family therapists in the clinical experience 
of the authors of the MMFF (Epstein et al., 2003).  
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As with problem solving, the MMFF divides communication into two areas, 
instrumental and affective (Epstein et al., 2003). In addition, the MMFF considers the 
style of communication in which the family engages. It does so along two independent 
continua, with one ranging from clear to masked and the other ranging from direct to 
indirect (Epstein et al., 2003). The clear vs. masked continuum refers to whether the 
message is expressed clearly or is vague and muddy. The direct vs. indirect distinction 
refers to whether the message is expressed to the intended recipient or to another member 
of the family (Miller et al., 2000).   
Therefore, within the MMFF there are considered to be four possible styles of 
communication: clear and direct, clear and indirect, masked and direct, and masked and 
indirect (Epstein et al., 2003). To illustrate each of these four possible styles, imagine a 
situation in which a wife is angry with her husband for coming home late from work 
without calling. An example of clear and direct communication in this circumstance 
would be if she told him “I am upset that you are late and I wish you would have called to 
tell me you would be late.” An example of clear and indirect communication would be if 
the wife told their daughter, in the presence of the husband, “I am upset with your father 
because he was late and did not call to tell me that he would be.” An example of masked 
and direct communication would be if the wife said to her husband “Traffic must have 
been really bad for you to be getting home at this time.” Finally, an example of masked 
and indirect communication would be if the wife told the daughter, in the presence of her 
husband, “It’s really annoying when I don’t know what time people are planning to be 
home for dinner.” Although the model focuses on verbal communication, it does take into 
account nonverbal behavior, especially in so far as it contradicts the information that is 
being verbally exchanged, as this is thought to reflect masking or indirectness or both 
(Epstein et al., 2003).  
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According to the MMFF, most effective functioning in this domain occurs when 
(a) the family is able to communicate well about both instrumental and affective matters 
and (b) when the communication is clear and direct (Epstein et al., 2003). Least effective 
functioning is thought to occur when the communication in the family is masked and 
indirect (Epstein et al., 2003). 
Role functioning. 
Within the MMFF, roles are defined as the patterns of behavior family members 
engage in so as to fulfill the family’s functions (Epstein et al., 2003; Lebow & Stroud, 
2011; Miller et al, 2000). According to the MMFF, there are five basic types of family 
functions that are necessary for the maintenance of an effective and healthy family 
system: provision of resources, nurturance and support, adult sexual gratification, 
personal development, and maintenance and management of the family system (Epstein 
et al., 2003). Each of these areas includes a number of tasks and functions. The ‘provision 
of resources’ area includes tasks and functions related to the attainment of food, clothing, 
shelter, and other basic human needs. The ‘nurturance and support’ area includes tasks 
related to providing members of the family with warmth, comfort, and reassurance. The 
‘adult sexual gratification’ area involves ensuring that each adult partner is satisfied with 
the level of sexual intimacy present in the relationship. ‘Personal development’ tasks and 
functions include those related to the physical, emotional, educational, social, and 
professional development of each family member. Finally, the ‘maintenance and 
management of the family system’ area includes a variety of functions and tasks related 
to decision making/leadership, boundaries, finances, discipline, and health (Epstein et al., 
2003). 
The MMFF identifies two aspects of role functioning that are deemed to be vital 
to effective family functioning: role allocation and role accountability (Epstein et al., 
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2003). Role allocation involves the family’s patterns for the assignment of roles and role 
accountability refers to the ways in which the family ensures that roles are fulfilled 
(Epstein et al., 2003). An example is the task of taking out the trash, a part of the 
provision of resources area of family role functioning. The parents discussing amongst 
themselves who will be responsible for taking out the trash and deciding together that it 
will be their oldest son’s job to do so would be an example of role allocation. The use of 
a sticker chart to monitor whether or not the son has accomplished this task would be an 
example of role accountability.     
Most effective functioning occurs when all of the family functions have been 
clearly allocated to the appropriate family member(s) and when accountability is 
maintained (Epstein et al., 2003). Least effective functioning occurs when necessary 
family functions are unaddressed and when either allocation or accountability is not 
maintained (Epstein et al., 2003).  
Affective responsiveness. 
Affective responsiveness within the MMFF relates to the family’s range of 
emotional responses to stimuli, both in terms of quality and quantity (Epstein et al., 2003; 
Lebow & Stroud, 2011; Miller et al., 2000). The qualitative aspect refers to the ability of 
the family to respond with a spectrum of human emotions, as well as whether or not the 
emotion experienced matches the stimuli and/or context (Epstein et al., 2003). The 
quantitative aspect refers to the degree of affective response expressed, and ranges from 
absence of response to over-responsiveness, with reasonable or expected responsiveness 
in the middle (Epstein et al., 2003). The MMFF identifies two groups of affect: welfare 
emotions (such as love, joy, and concern) and emergency emotions (such as sadness, fear, 
and anger; Epstein et al., 2003). 
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Most effective functioning is defined as occurring when the family experiences a 
full range of qualitatively and quantitatively appropriate responses to stimuli. Least 
effective functioning occurs when only a narrow range of affect is experienced or when 
the amount and quality of affective responses are inappropriate for the context in which 
they occur (Epstein et al., 2003).  
Affective involvement. 
The MMFF defines affective involvement as the degree to which the family 
demonstrates interest in and values the activities and interests of individual family 
members (Epstein et al., 2003; Lebow & Stroud, 2011; Miller et al., 2000). This 
dimension focuses both on the amount of interest the family shows as well as the way(s) 
in which they demonstrate that interest (Epstein et al., 2003). The model identifies six 
types of affective involvement: lack of involvement, involvement devoid of feelings, 
narcissistic involvement, empathic involvement, overinvolvement, and symbiotic 
involvement (Epstein et al., 2003). These types exist on a continuum, with ‘lack of 
involvement’ at one extreme and ‘symbiotic involvement’ at the other. 
‘Lack of involvement’ occurs when family members have no interest or 
investment in one another’s lives. ‘Involvement devoid of feelings’ is when family 
members have a purely intellectual interest in one another. ‘Narcissistic involvement’ 
occurs when a family member is only interested in another family member to the extent 
that the other member’s behavior reflects upon themselves. ‘Empathic involvement’ takes 
place when family members’ interest in each other is for the sake of the other person. 
‘Overinvolvement’ happens when family members show an excessive amount of interest 
in one another. Finally, ‘symbiotic involvement’ occurs when family members are 
invested in one another to such an extreme and pathological extent that it is difficult to 
differentiate between the individual members of the family. Empathic involvement is 
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thought to contribute to most effective functioning in this dimension, with symbiotic 
involvement and absence of involvement leading to least effective functioning (Epstein et 
al., 2003).  
Behavior control. 
The final dimension of family functioning within the MMFF, behavior control, is 
the pattern of standards and rules set by the family in order to handle the behavior of its 
members in a variety of situations (Epstein et al., 2003; Lebow & Stroud, 2011; Miller et 
al., 2000). These situations are grouped into three types: physically dangerous situations, 
situations involving psychobiological needs, and situations that involve interpersonal 
socialization, both within and outside of the family (Epstein et al., 2003). Each of these 
types of situations may require different sets of standards and rules from the family. 
In addition to the standards and rules set by the family in these areas, the MMFF 
is also interested in the amount of latitude that the family allows relative to these 
standards and rules (Epstein et al., 2003). Included in the model are four styles of 
behavior control that vary in terms of standards and latitude: rigid behavior control, 
flexible behavior control, laissez-faire behavior control, and chaotic behavior control 
(Epstein et al., 2003). Rigid behavior control occurs when the family’s standards for 
behavior are quite narrow and specific and the family allows for very little variation or 
negotiation between situations. In flexible behavior control, the standards set by the 
family are reasonable and may vary or be negotiable depending on the context or 
situation. With laissez-faire behavior control, the family holds no standards for the 
behavior of its members, allowing members complete latitude regardless of the situation. 
Finally, a chaotic behavior control style consists of a random and unpredictable 
vacillation between the three previous styles of behavior control, such that members of 
the family never know what to expect. Most effective functioning is associated with a 
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flexible behavior control style and least effective functioning is associated with a chaotic 
behavior control style (Epstein et al., 2003).  
Dimensions of family functioning among families of pediatric ALL survivors. 
Consideration of family functioning is crucial to a comprehensive understanding 
of the experience of survivors of pediatric ALL because childhood cancer is in many 
ways a family affair (Alderfer, Navsaria, & Kazak, 2009; Butler & Copeland, 2006). A 
diagnosis of a potentially terminal illness such as ALL in a child poses a significant 
challenge to the functioning of that child’s family (Alderfer et al., 2009). Families of 
children receiving cancer treatment have been found to demonstrate lower levels of 
functioning than families of children who have completed treatment, but even “off-
treatment” families have been found to show evidence of long-term disruptions in family 
functioning (Alderfer et al., 2009).  
Research examining family functioning among adolescent survivors of childhood 
cancer and their families has found higher levels of self-reported difficulties in family 
functioning among this population (Alderfer et al., 2009). One study that used a self-
report measure of family functioning based on the MMFF found that 35-62% of 
adolescent survivors and 17-44% of their parents reported poor levels of family 
functioning in at least one of the six dimensions of the MMFF (Alderfer et al., 2009). In 
that study, almost half of the adolescent survivors, one fourth of their mothers, and one 
third of their fathers reported poor family functioning on four or more of the dimensions 
of family functioning included in the MMFF (Alderfer et al., 2009). These levels of self-
reported difficulties with family functioning are much higher than are typically found 
among community samples, in which less than 10% report poor functioning on that many 
dimensions (Alderfer et al., 2009). This indicates that the six dimensions of family 
 30 
functioning included in the MMFF are very relevant areas to consider when working with 
survivors of childhood ALL and their families.   
Family functioning and neurocognitive late effects in traumatic brain injury. 
Although the relationship between family functioning and neurocognitive 
functioning has not been studied among survivors of pediatric ALL, there is evidence 
from research on pediatric traumatic brain injury (TBI) that family variables, such as 
family functioning, may predict child neurocognitive outcomes following TBI (Hocking 
et al., 2011). Studies have found better family functioning to be positively associated with 
neurocognitive outcomes following pediatric TBI (Nadebaum, Anderson, & Catroppa, 
2007). Researchers began investigating family influences on neurocognitive sequelae in 
pediatric TBI after it had been found that pediatric TBI has a negative impact on families 
(Taylor et al., 1999). It was thought that the negative impacts of TBI upon the family 
might in turn make it difficult for the family to adequately support the child’s recovery 
from TBI (Taylor et al., 1999). Supporting this notion, there has been evidence linking 
family stress and ineffective parenting practices within the clinical literature (Taylor et 
al., 1999). Furthermore, studies performed on animals showed that environmental 
influences affected recovery of function (Taylor et al., 1999). Therefore, researchers in 
the field of pediatric TBI hypothesized that the long-term sequelae of pediatric TBI may 
be partially related to environmental factors such as family functioning (Taylor et al., 
1999). As there have been no reviews or meta-analyses conducted on this literature to 
date, each study investigating the relationship between family functioning and 
neurocognitive outcome following pediatric TBI will be examined individually. 
Yeates and colleagues (1997) examined the influence of injury severity and 
preinjury social environment on neurocognitive outcomes among children with severe 
TBI, moderate TBI, and a comparison group of children with orthopedic injuries (OI). 
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They assessed premorbid child and family characteristics during a baseline assessment 
shortly after the children’s injuries and child neurocognitive functioning was assessed at 
baseline and approximately 6 and 12 months postinjury (Yeates et al., 1997). They used 
growth curve analysis to test three hypotheses regarding the influence of injury severity 
and pre-injury social environment on neurocognitive outcome (Yeates et al., 1997). The 
measures of pre-injury family environment, which were used a predictors of 
neurocognitive outcomes, included the Family Assessment Device (FAD), a measure of 
family functioning based upon the MMFF (Yeates et al., 1997). There were three 
measures of cognitive functioning chosen as dependent variables. The first was a prorated 
Performance Scale IQ (PIQ) derived from a short form of the Wechsler Intelligence Scale 
for Children – Third Edition (WISC-III), which was used as a measure of nonverbal skills 
that has been found to be sensitive to the acute effects of TBI in children. The second 
measure of cognitive functioning was the total raw score from the Developmental Test of 
Visual–Motor Integration (VMI), a drawing task that requires visuoperceptual, 
constructional, and graphomotor skills and has been shown to be sensitive to TBI in 
children. The final measure of cognitive functioning used was the total number of words 
recalled across five learning trials on a shortened, preliminary version of the children’s 
California Verbal Learning Test (CVLT), a word-list learning task that measures verbal 
memory skills. Total recall on the CVLT has been shown to discriminate between 
children with TBI and matched controls.  
Yeates and colleagues (1997) found that the four family variables included in 
their analysis accounted for significant amounts of variance in each of their outcome 
measures, even after controlling for injury severity (group membership). In fact, the 
preinjury family environment accounted for a larger amount of variance in outcome at 12 
months post-injury than did injury severity. After controlling for injury severity and 
 32 
demographics, family environment accounted for as much as 25% of the variance in 
cognitive outcome following TBI.  
Furthermore, they found that family functioning moderated the effect of TBI in 
that children from families with above-average family functioning tended to experience a 
more rapid and complete recovery from TBI, while children from families with below-
average family functioning tended to experience a slower and less complete recovery. 
Specifically, below average family functioning was associated with lower amounts of 
cognitive improvement over the course of the first year postinjury and worse cognitive 
outcomes at 12-months post injury. For example, the difference between the severe TBI 
and the OI groups in total recall scores on the CVLT at 12-months postinjury was directly 
proportional to measured family functioning. For children whose FAD scores reflected 
above-average family functioning (i.e., scores were 1 standard deviation below the mean, 
as lower scores on the FAD reflect better family functioning), the group difference was 
only 2.69 words. However, for children whose FAD scores were reflective of below-
average family functioning (i.e., 1 standard deviation above the mean), the difference 
between the severe TBI and the OI groups was 9.23 words. Therefore, a difference of 2 
standard deviations on the FAD resulted in a more “than 1 standard deviation increase in 
the discrepancy between the OI and severe TBI groups” in memory functioning (Yeates 
et al., 1997, p. 626).  
The results of this study support the notion that family variables help to determine 
children’s neurocognitive functioning following TBI and that the child’s family 
environment moderates the impact of TBI (Yeates et al., 1997). Specifically, this study 
found that the deficits in memory functioning that are associated with severe TBI were 
cushioned by above-average family functioning and made worse by below-average 
family functioning (Yeates et al., 1997). Furthermore, their finding that environmental 
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measures such as family functioning accounted for at least as much, or more, variance in 
level of neurocognitive outcome than did measures of injury severity suggests that the 
child’s eventual neurocognitive functioning following a TBI depends as much, if not 
more, on environmental influences than on injury-related variables (Yeates et al., 1997).  
In a later report on findings extending this research by Yeates and colleagues, 
Taylor et al. (1999) examined whether postinjury family environment was related to 
concurrent child outcomes in TBI. They looked at three aspects of the family 
environment: family dysfunction, parental psychological distress, and injury-related 
family burden (Taylor et al., 1999). They assessed patients at baseline (shortly after 
injury), at 6 months postbaseline, and at 12 months postbaseline (Taylor et al., 1999). 
There were three groups of children included in the study: children with severe TBI, 
children with moderate TBI, and children with an orthopedic injury not involving insult 
to the CNS (Taylor et al., 1999). The orthopedic group was included in order to control 
for possible confounding variables such as proneness to accidents, the experience of 
hospitalization, and practice effects from repeated testing, as well as to examine possible 
differential consequences of TBI as opposed to non-CNS related injury (Taylor et al., 
1999). As with the previous report, the measure of family functioning used in this study 
was the General Functioning scale of the FAD (Taylor et al., 1999). However, a much 
more comprehensive neurocognitive test battery was administered to the patients in this 
aspect of the study. The specific domains examined included global cognitive ability, 
language skills, perceptual-motor skills, memory, attention, academic achievement, 
school performance, behavior problems, child competence, and adaptive behavior.  
They examined the influence of post-injury family status at the 6- and 12-month 
follow-ups on concurrent child outcomes via hierarchical linear regression (Taylor et al., 
1999). This study found that these post-injury measures of family function predicted 
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concurrent child outcomes at both the 6- and 12-month follow-ups (Taylor et al., 1999). 
Higher levels of concurrent family functioning were associated with better child 
functioning, even after controlling for injury severity and pre-injury family functioning 
(Taylor et al., 1999). Furthermore, they found an interaction between group contrasts and 
family functioning, such that the group effect of severe TBI vs. orthopedic group 
interacted with the FAD-GF in predicting verbal memory, math skills, and teacher ratings 
of academic performance (Taylor et al., 1999). Specifically, this study found that the 
differences in outcomes between severe TBI and orthopedic injury in these domains were 
more pronounced in children from families with higher levels of dysfunction at both 6- 
and 12-months post baseline (Taylor et al., 1999).  
Other studies have also found support for a link between family functioning and 
memory functioning among pediatric TBI patients. Max and colleagues used the 
McMaster Structured Interview of Family Functioning (Mc-SIFF), a clinical research 
interview based upon the MMFF, to assess family functioning (Max et al., 1999). The 
Mc-SIFF is used in order to obtain scores on a rating scale named the Clinical Rating 
Scale (CRS), which contains seven items corresponding to the seven domains of family 
functioning included in the MMFF (Max et al., 1999). They utilized the global score from 
the CRS in their analyses (Max et al., 1999). Max and colleagues (1999) assessed 
intellectual and memory functioning among children with severe traumatic brain injuries, 
mild traumatic brain injuries, and orthopedic injuries using the WISC-R and the 
WRAML. Specifically, they used a prorated PIQ score, a prorated VIQ score, and a FIQ 
score from a short form of the WISC-R and a Verbal Memory Index and Visual Memory 
Index from the WRAML in their analyses. Max and colleagues began with eight 
independent variables: family psychiatric history, duration of impaired consciousness, 
family functioning, lowest post-resuscitation score on the Glasgow Coma Scale (a 
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measure of responsiveness to stimuli following a TBI), neurological exam, “novel” post-
injury psychiatric disorder, pre-injury psychiatric disorder, and socioeconomic status 
(Max et al., 1999).  
The researchers found that intellectual and memory function outcome in pediatric 
brain injury was significantly related to a Psychosocial Disadvantage Factor that included 
family dysfunction (Max et al., 1999). Notably, this study found that family functioning, 
together with family psychiatric history, added significantly to SES in explaining 
cognitive outcomes two years after injury. While causation certainly could not be inferred 
from this cross-sectional study, the results do suggest that psychosocial disadvantage 
factors such as poor family functioning influence children’s cognitive outcomes from 
TBI (Max et al., 1999). This study supported the findings of Yeates et al. and Taylor et 
al., and added findings related to general intellectual functioning as well. 
A more recent study found similar results in the domains of attention/executive 
functioning. Nadebaum and colleagues investigated long-term attention/executive 
functioning among survivors of pediatric TBI (Nadebaum, Anderson, & Catroppa, 2007). 
Their study consisted of 54 children who had sustained a TBI and 17 healthy control 
subjects who were selected to match the TBI group as closely as possible in terms of age, 
gender, SES, and pre-injury abilities (Nadebaum, Anderson, & Catroppa, 2007). Family 
functioning was assessed using the Family Functioning Questionnaire (FFQ), which 
parents completed at baseline and five years post-injury (Nadebaum, Anderson, & 
Catroppa, 2007). They used four cognitive measures to assess the various subcomponents 
of EF included in Anderson’s model (Anderson, 2002). These included Sky Search from 
the Test of Everyday Attention for Children (TEA-Ch) for attentional control (sustained 
attention), Score DT from the TEA-Ch for cognitive flexibility (divided attention), Block 
Design from the Wechsler Intelligence Scales for Children-III (WISC-III) for goal setting 
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(organization and perceptual reasoning), and the Processing Speed Index from the WISC-
III (a composite of the Coding and Symbol Search subtests) for information processing 
(efficiency and speed of information processing). They also administered the Parent Form 
of the Behavior Rating Inventory of Executive Function (BRIEF), a rating scale that 
measures behavioral manifestations of executive dysfunction. The BRIEF was 
administered at baseline and five years post-injury, whereas the cognitive measures were 
only administered five years post-injury.  
As with Taylor et al., Nadebaum and colleagues utilized hierarchical linear 
multiple regression analyses to identify factors that predicted EF outcome. They found 
that pre-injury family functioning was a significant predictor of Processing Speed Index 
scores, with higher scores associated with higher levels of family functioning. Family 
functioning also significantly predicted overall EF outcome (performance on the 
composite measure of EF), with better pre-injury family functioning again associate with 
better outcomes.  
Summary. 
Using different measures of family functioning, researchers have identified a 
protective influence on children’s immediate and longer-term recovery from traumatic 
brain injury. Pre-injury family functioning, as reported at the time of injury, explained 
significant amounts of variance in executive functioning, memory, and intellectual 
outcomes at 6- and 12-months as well as 2- and 5-years postinjury (Max et al., 1999; 
Nadebaum, et al., 2007; Yeates, et al., 1997). Concurrent family functioning was also 
found to explain significant amounts of variance in memory and academic achievement at 
6- and 12-months postinjury (Taylor et al., 1999). One interpretation of the findings of 
these studies is that the neurocognitive effects of TBI make these children more 
vulnerable to family influences than their peers who have not sustained a head injury 
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(Taylor et al., 1999). Also, it could be that families with higher levels of dysfunction lack 
the ability to adequately support the child’s recovery from TBI, such that the child does 
not have enough opportunity or motivation necessary to perform the practice of cognitive 
skills that is necessary for a more complete neurocognitive recovery from TBI (Taylor et 
al., 1999). Another interpretation is that a positive family environment actually facilitates 
neural recovery (Taylor et al., 1999). This hypothesis has been supported in studies with 
animals, but has little empirical support to date from studies of human recovery of 
function (Taylor et al., 1999).  
Family functioning and neurocognitive late effects in pediatric brain tumors. 
In one of the only studies to examine the impact of family functioning on 
neurocognitive functioning among pediatric cancer patients, Carlson-Green and 
colleagues investigated the ability of family measures to predict the cognitive functioning 
of 63 children being treated for brain tumors (Carlson-Green et al., 1995). They used 
hierarchical multiple regression to determine whether or not family variables improved 
prediction of child outcomes over and above illness variables and covariates. Illness 
variables included measures of neurological symptoms and treatment severity. Family 
predictors included measures of maternal coping resources, family cohesion, family 
control, and family stressors. Cognitive outcome variables included a measure of 
intelligence and a measure of achievement. The covariates included in the model were 
time since diagnosis, SES, age at diagnosis, and parental marital status. In terms of 
cognitive outcomes, they found that family variables did explain a significant amount of 
variance in child intellectual outcome, with the most parsimonious model including both 
family (maternal coping resources) and illness (treatment severity) measures, as well as 
covariate measures (time since diagnosis, SES, and marital status). Family variables did 
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not account for any additional variance above illness factors in predicting child 
achievement outcomes.  
Summary. 
In summary, research from the fields of pediatric traumatic brain injury and 
pediatric brain tumors has shown that psychosocial variables such as family functioning 
moderate neurocognitive outcomes among these populations (Carlson-Green et al., 1995; 
Max et al., 1999; Nadebaum et al., 2007; Taylor et al., 1999; Yeates et al., 1997). 
Specifically, positive family functioning has been found to serve as a protective factor 
against the development of neurocognitive deficits in areas of neurocognitive functioning 
typically affected by TBI and brain tumors. This phenomenon has not yet been studied 
among survivors of pediatric ALL. 
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Chapter Three: Proposed Research Study 
State of Problem 
Some variables that seem to moderate neurocognitive outcome among survivors 
of pediatric ALL treated with chemotherapy-only have been identified, including gender, 
age at diagnosis, time since diagnosis, and socioeconomic status (Brouwers, 2005; Buizer 
et al., 2009; Moleski, 2000; Mulhern & Palmer, 2003; Patel & Carlson-Green, 2005; 
Peterson et al., 2008; Stehbens et al., 1994; Waber et al., 2011; Winick, 2011). However, 
much less is known about potential psychosocial moderators such as family functioning 
(Anderson & Kunin-Batson, 2009; Patel & Carlson-Green, 2005). Evidence from the 
pediatric traumatic brain injury and pediatric brain tumor populations suggests that 
positive family functioning serves as a protective factor for neurocognitive outcomes of 
children who survive these conditions (Carlson-Green et al., 1995; Max et al., 1999; 
Nadebaum et al., 2007; Taylor et al., 1999; Yeates et al., 1997). No research has been 
done to see whether positive family functioning similarly moderates the effects of CNS-
directed chemotherapy on the neurocognitive functioning of survivors of pediatric ALL. 
Identification of all possible protective factors for neurocognitive outcomes among 
survivors of pediatric ALL is necessary in order to design, research, and implement 
effective interventions in order to lessen the prevalence of neurocognitive late effects 
among this population. 
Statement of Purpose 
The purpose of this proposed study is to examine the effect of family functioning 
upon neurocognitive outcome among survivors of pediatric ALL treated with 
chemotherapy. Specifically, the proposed study seeks to determine if positive family 
functioning serves as a protective factor against the neurocognitive deficits commonly 
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seen in this population. Based upon a multidimensional model of attention and 
Anderson’s model of executive function (EF), four subcomponents of attention and four 
subcomponents of EF will be examined (Anderson, 2002). The attention subcomponents 
are: selective, divided, sustained, and shifting. The EF subcomponents are: cognitive 
flexibility (working memory), goal setting (planning), attentional control (inhibition), and 
information processing (processing speed).  It is hypothesized that family functioning 
will add to such moderating factors as age at diagnosis, gender, time since diagnosis, and 
SES in predicting neurocognitive outcome in the domains listed above.  
Research Questions and Hypotheses 
 Research question 1. 
Does positive family functioning protect against deficits in attention among 
survivors of pediatric ALL, specifically in the subdomains of selective attention, divided 
attention, sustained attention, and shifting attention, and as reported by parents?  
Hypothesis 1. 
Differences in family functioning will account for a significant amount of the 
variance in performance on a task of selective attention for survivors of pediatric ALL 
but not for healthy controls.  
Differences in family functioning will account for a significant amount of the 
variance in performance on a task of divided attention for survivors of pediatric ALL but 
not for healthy controls.  
Differences in family functioning will account for a significant amount of the 
variance in performance on a task of sustained attention for survivors of pediatric ALL 
but not for healthy controls.  
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Differences in family functioning will account for a significant amount of the 
variance in performance on a task of shifting attention for survivors of pediatric ALL but 
not for healthy controls.  
Differences in family functioning will account for a significant amount of the 
variance in scores on parent ratings of inattention for survivors of pediatric ALL but not 
for healthy controls.  
Rationale. 
Survivors of pediatric ALL treated with chemotherapy have been found to have 
deficits in selective, divided, sustained, and shifting attention and in parent ratings of 
attention (Anderson & Kunin-Batson, 2009; Ashford et al., 2010; Bisen-Hersh et al., 
2011; Butler & Copeland, 2002; Carey et al., 2008; Harila et al., 2009; Kingma et al., 
2002; Lesnik et al, 1998; Reddick et al., 2006). Family functioning has been found to 
moderate neurocognitive outcome in survivors of pediatric traumatic brain injury and 
brain tumor in domains sensitive to insult in those populations (Carlson-Green et al., 
1995; Max et al., 1999; Nadebaum et al., 2007; Taylor et al., 1999; Yeates et al., 1997). It 
is expected that family functioning will similarly moderate neurocognitive outcomes in 
the ALL population in attention, a domain sensitive to insult in this population. 
Furthermore, it is expected that positive family functioning will serve as a protective 
factor against the development of attention problems among survivors of pediatric ALL. 
It is thought that higher functioning families may be better able to manage survivors’ 
neurocognitive late effects, for example, by providing opportunities for the survivor to 
practice and strengthen the attentional skills that have been negatively impacted by the 
chemotherapy treatment. In alignment with Rose and colleagues’ conceptualization of 
protective factors as operating only in instances of adversity, it is expected that children 
in the healthy control group, who have not been exposed to adversity in the form of CNS 
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prophylaxis, will not demonstrate the same relationship between family functioning and 
performance on measures of attention (Rose, Holmbeck, Coakley, & Franks, 2004).  
Research question 2. 
Does positive family functioning protect against deficits in executive functioning 
among survivors of pediatric ALL, specifically in the subdomains (areas) of cognitive 
flexibility (working memory), goal setting (planning), attentional control (inhibition), 
information processing (processing speed) and as reported by parents? 
Hypothesis 2. 
Differences in family functioning will account for a significant amount of the 
variance in performance on a task of cognitive flexibility (working memory) for survivors 
of pediatric ALL but not for healthy controls.  
Differences in family functioning will account for a significant amount of the 
variance in performance on a task of goal setting (planning) for survivors of pediatric 
ALL but not for healthy controls.  
Differences in family functioning will account for a significant amount of the 
variance in performance on a task of attentional control (inhibition) for survivors of 
pediatric ALL but not for healthy controls.  
Differences in family functioning will account for a significant amount of the 
variance in performance on a task of information processing (processing speed) for 
survivors of pediatric ALL but not for healthy controls.  
Differences in family functioning will account for a significant amount of the 
variance in scores on parent ratings of executive functioning for survivors of pediatric 
ALL but not for healthy controls.  
Rationale. 
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Survivors of pediatric ALL treated with chemotherapy have been found to have 
deficits in executive functioning, including working memory, inhibition, processing 
speed, and planning, and on parent ratings of executive functioning (Ashford et al., 2010; 
Buizer et al., 2009; Harila et al., 2009; Jansen et al., 2008; Kingma et al., 2002; Lesnik et 
al., 1998; Waber et al., 1995). Family functioning has been found to moderate 
neurocognitive outcome in survivors of pediatric traumatic brain injury in the domain of 
executive functioning (Nadebaum et al., 2007). It is expected that a similar moderating 
effect of family functioning on executive functioning will exist among the ALL 
population. Moreover, it is expected that positive family functioning will serve as a 
protective factor against the development of deficits in executive functioning among 
survivors of pediatric ALL. As such, it is expected that children in the healthy control 
group, who have not been exposed to adversity in the form of CNS prophylaxis, will not 
demonstrate the same relationship between family functioning and performance on 
measures of attention (Rose et al., 2004).  
Method 
 Participants. 
Participants in this study will include 85 children and adolescents who have 
completed chemotherapy-only treatment for ALL and 85 healthy control participants, 
equaling a total of 170 participants (N = 170). In order to match epidemiological figures 
of ALL set forth by McNeil et al. (2002), the groups will be comprised of the following 
percentages: 57% male, 43% female; 83% white, 7% black, 9% other. Control 
participants will be recruited from the same zip codes as the survivors in order to 
minimize between-groups differences in socioeconomic status. The rationale for 
including a healthy control group was to permit investigation of family functioning as 
protective factor, that is, as a moderator of outcome in the presence of adversity (Rose et 
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al., 2004). All participants will be within the ages of 8 and 16. This age range was chosen 
so that all participants in the study could be evaluated using the same battery of 
neuropsychological tests.  
Inclusion criteria will be: (i) aged 8 to 16 years throughout the length of the study, 
(ii) post-treatment and having been designated as survivors of pediatric Acute 
Lymphoblastic Leukemia (ALL) by the LIVESTRONG Survivorship Center at Dell 
Children’s Medical Center in Austin, Texas, and (iii) English-speaking. Patients are 
typically designated as survivors after completion of treatment and one year of being 
cancer-free. Individuals meeting school criteria as having a visual or auditory impairment 
or attention difficulties such as attention-deficit/hyperactivity disorder (ADHD) will be 
excluded from the study. Additionally, individuals who are undergoing treatment for 
ALL at the time of the study, who underwent a bone-marrow transplant or cranial 
radiation therapy, had a recurrence of cancer, or who had impaired global cognitive 
functioning (e.g. mental retardation) will not be included in this investigation. Power 
analyses were conducted to determine the number of participants needed to detect a 
significant effect for the multiple regression analyses. A sample size of 170 was 
determined to be the minimum number needed to detect a significant effect for both tests.  
Instruments. 
Participants will be administered measures of attention and executive functioning 
and their parents will be asked to complete rating forms about their attention and 
executive functioning. Additionally, one parent of each child involved in the study will 
complete a measure of family functioning.  
Attention measures. 
Test of Everyday Attention – Children’s Version (TEA-Ch). The Test of Everyday 
Attention for Children (TEA-Ch; Manly, Robertson, Anderson, & Nimmo-Smith, 1999) 
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is a children’s adaptation of the adult Test of Everyday Attention (TEA). It has been used 
in research with males with Fragile X syndrome, girls with Turner’s syndrome, and 
children with head injury, ADHD, and learning disabilities (Baron, 2004). The full TEA-
Ch is comprised of 9 subtests and a full administration takes approximately 1 hour. 
However, there is also a four-subtest screener version that takes 20-25 minutes to 
administer and assesses each of the four dimensions of attention (selective, divided, 
sustained, and shifting). The normative sample for the TEA-Ch was comprised of 293 
Australian children and adolescents between the ages of 6 years, 7 months and 16 years, 
11 months and included equal numbers of males and females. The sample was divided 
into six age bands, with 29 to 58 children in each age band. Reported test-retest 
reliabilities for the TEA-Ch range from .57 to .87, with percentage agreement values 
ranging from 71% to 76% (Manly et al, 1999). A structural equation modeling study 
involving the normative sample resulted in a three-factor model of sustained attention, 
attentional control/switching, and selective attention (Manly et al., 2001).  
The four-subtest screener version of the TEA-Ch will be used in this study to 
assess the four subdomains of attention described previously. The specific subtests that 
will be administered are: Sky Search, Score!, Creature Counting, and Sky Search DT. 
Sky Search is a measure of selective attention that requires the subject to filter 
information in order to detect relevant information while rejecting or inhibiting 
distracting information (Baron, 2004; Manly et al., 1999). The reported test retest 
correlation coefficient from the normative sample for this subtest was 075. Score! is a 
measure of sustained attention that requires the subject to count tones played on an audio 
recording and report the correct number of tones at the end of each round (Baron, 2004; 
Manly et al., 1999). The reported percentage agreement from the normative sample for 
this subtest was 76.2%. Creature Counting is a measure of switching attention that 
 46 
requires the subject to count stimuli according to visual cues indicating for them to count 
either upwards or downwards (Baron, 2004; Manly et al., 1999). There are two scores 
available for this subtest: an accuracy score and a timing score. For the proposed study, 
the accuracy score will be used as a measure of switching attention. The reported test 
retest correlation coefficient from the normative sample for this measure was 0.71. Sky 
Search DT is a measure of divided attention that requires the subject to circle certain 
stimuli while also keeping count of auditory tones (Baron, 2004; Manly et al., 1999). The 
reported test retest correlation coefficient from the normative sample for this subtest was 
0.81.  
Behavior Assessment System for Children – Second Edition (BASC-2). The 
Behavior Assessment System for Children – Second Edition (BASC-2; Reynolds & 
Kamphaus, 2004) is a comprehensive set of rating scales and forms that assess behavioral 
and emotional functioning of children and adolescents, including teacher, parent, and 
self-report versions. There are various forms of each of the three versions for use with 
different age groups, ranging from 2 years old through college age. For this study, the 
child (ages 6 to 11) and adolescent (ages 12 to 21) forms of the Parent Rating Scales 
(PRS) will be used. These scales contain a number of items (134-160) that describe 
specific patterns of behavior and are rated on a four-point frequency scale ranging from 
“never” to “almost always”. The child and adolescent forms of the BASC-2 PRS were 
each standardized on a sample of 1,800 individuals representative of the U.S. population 
in terms of socioeconomic status, race/ethnicity, and geographic region according to 
figures from the March 2001 Current Population Survey. For the purposes of this study, 
the “Attention Problems” scale from the PRS will be used in assessing parental report of 
children’s attentional abilities. Reported coefficient alpha reliabilities from the normative 
sample for the attention problems scale on the child and adolescent forms of the PRS 
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range from .85 to .88. Adjusted test-retest reliability coefficients for this scale are 0.81 for 
the adolescent form and 0.85 for the child form. 
Executive functioning measures. 
Delis-Kaplan Executive Function System (D-KEFS). The Delis-Kaplan Executive 
Function System (D-KEFS; Delis, Kaplan, & Kramer, 2001) is a standardized battery of 
tests that measure a variety of executive functions in people age 8 through 89 years. The 
D-KEFS was standardized on a nationally representative sample of 1750 people ages 8-
89 years. The sample was stratified in regards to age, sex, race/ethnicity, years of 
education, and geographic region using figures from the 2000 U.S. Census. For this 
study, the following two subtests of the D-KEFS will be administered: the D-KEFS 
Tower Test and the D-KEFS Color-Word Interference Test. The D-KEFS Tower Test is a 
measure of planning (Baron, 2004; Delis et al., 2001). Specifically, the Total 
Achievement scaled score will be used as a measure of planning. Reported internal 
consistency values for this measure for children ages 8-16 ranged from 0.43 to 0.84. The 
reported test-retest reliability coefficient for this age group was 0.51. The D-KEFS Color-
Word Interference Test is a measure of inhibition (Baron, 2004; Delis et al., 2001). 
Specifically, the Trial 3: Inhibition time scaled score will be used as a measure of 
inhibition. The reported test-retest reliability coefficient for this measure for children ages 
8-16 was 0.90. 
Wechsler Intelligence Scale for Children – Fourth Edition (WISC-IV). The 
Wechsler Intelligence Scale for Children – Fourth Edition (WISC-IV; Wechsler, 2003) is 
a widely used measure of cognitive ability. It is comprised of fifteen subtests, ten in the 
core battery and five that are supplemental. It is designed for children age 6:0 through 
16:11 and takes 65 to 80 minutes to administer in full. The WISC-IV yields a measure of 
global cognitive ability, the Full Scale IQ (FSIQ), as well as four composite scores: the 
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Verbal Comprehension Index (VCI), the Perceptual Reasoning Index (PRI), the Working 
Memory Index (WMI), and the Processing Speed Index (PSI). The WISC-IV was 
standardized on a nationally representative sample of 2,200 children, stratified according 
to March 2000 U.S. Census data along the variables of age, sex, race/ethnicity, parent 
education level, and geographic region. 
For the purposes of this study, four subtests of the WISC-IV will be administered 
to participants. These are the Digit Span and Letter-Number Sequencing subsets, which 
together comprise the WMI, and the Symbol Search and Coding subtests, which together 
comprise the PSI. Digit Span consists of two parts, Digit Span Forward (DSF) and Digit 
Span Backward (DSB). On DSF, the subject is required to repeat verbatim numbers 
presented to them orally. On DSB, the subject has to repeat numbers in the reverse order 
of that in which they are presented. Scores on these two components are combined to 
produce a total Digit Span scaled score. The reported overall average reliability 
coefficient from the normative sample for this subtest was 0.87. Letter-Number 
Sequencing requires the subject to listen to strings of mixed numbers and letters and to 
repeat the string with numbers first, in numerical order, followed by letters in 
alphabetical order. The reported overall average reliability coefficient from the normative 
sample for this subtest was 0.90. Symbol Search requires the subject to visually scan a 
group of stimuli and indicate whether or not a target stimulus is present. The reported 
overall average reliability coefficient from the normative sample for this subtest was 
0.79. Coding requires the subject to copy symbols paired with shapes or numbers within a 
given time limit. The reported overall average reliability coefficient from the normative 
sample for this subtest was 0.85. 
Behavior Rating Inventory of Executive Function (BRIEF). The Behavior Rating 
Inventory of Executive Function (BRIEF; Gioia, Isquith, Guy, & Kenworthy, 2000) 
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consists of two forms, a parent questionnaire and a teacher questionnaire. Each form 
consists of 86 items scored on a 3-point scale (Never, Sometimes, Often). It takes 
approximately 10 to 15 minutes to complete and can be used with children ages 5 to 18 
years. The BRIEF assess eight subdomains of executive function: inhibition, shifting, and 
emotional control, which together comprise a broader composite score called the 
Behavioral Regulation Index (BRI), and initiation, working memory, 
planning/organizing, organization of materials, and monitoring, which together comprise 
the Metacognition Index (MI) composite. The BRI and MI are then combined to produce 
the overall Global Executive Composite (GEC) score. For this study, the GEC from the 
parent form of the BRIEF will be used as a measure of overall executive functioning as 
reported by parents. The parent form of the BRIEF was standardized on a sample of 
1,419 parents from urban, suburban, and rural areas of Maryland. The sample was 
representative of 1999 U.S. Census data in regards to gender, socioeconomic status, 
ethnicity, age, and geographical population density. The reported Cronbach’s α for the 
GEC on the Parent Form of the BRIEF is 0.97. Reported test-retest reliability for the 
GEC is 0.91.  
Family functioning measure. 
Family Assessment Device (FAD). Family functioning will be measured using the 
Family Assessment Device (FAD), a well-established self-report measure of family 
functioning based upon the McMaster Model of Family Functioning. It consists of six 
scales representing the six dimensions of family functioning included in the MMFF, as 
well as a General Functioning Scale (GFS) that provides a measure of overall family 
functioning based upon the other six scales. The FAD consists of 60 items about families, 
and asks the rater to indicate how much each item describe their family’s functioning on 
a 4-point Likert scale that ranges from strongly agree to strongly disagree. The FAD 
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takes approximately 20 minutes to complete and can be administered to any family 
member over the age of 12. Higher scores on the scales of the FAD indicate higher levels 
of family dysfunction. It will be administered one adult from each family participating in 
the study. For the purposes of this study, the FAD GFS will be used as a measure of 
overall family functioning. Kabacoff and colleagues conducted a study of the 
psychometric properties of the FAD among nonclinical (n = 627), psychiatric (n = 1,138) 
and medical (n = 298) samples (Kabacoff, Miller, Bishop, Epstein, & Keitner, 1990). 
Cronbach alphas for the GFS among these samples were .83, .84, and .86, respectively.   
Procedure. 
Approval by human subjects committee. 
This study will be conducted in compliance with the ethical standards set forth by 
the American Psychological Association and The University of Texas at Austin.  All 
research materials will be approved prior to data collection by the Departmental Review 
Committee within the Department of Educational Psychology and by the Institutional 
Review Board of The University of Texas at Austin.   
Recruitment of participants. 
Participants for the experimental group will be recruited through the 
LIVESTRONG Survivorship Center in Austin, Texas. Children designated by their 
oncologists as survivors of pediatric ALL and who meet the inclusion criteria will be 
invited to participate in the study. All such children and adolescents, regardless of length 
of survivorship status, will be invited to participate in order to maximize the potential 
sample size. Control participants will be solicited through local school districts. With the 
permission of district officials, advertisements will be placed on bulletin boards around 
the schools, in newsletters sent home to parents, and on school websites. As an incentive 
for participation in the study, each child in the control group will be entered into a raffle.   
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Consent. 
 Participation in the study will be voluntary and participants will be able to 
discontinue participation at any time, for any reason. Guardians of all participants will 
receive a copy of the consent form and will have the chance to discuss any concerns with 
the researcher. Participants themselves will be given assent forms and the chance to 
discuss any concerns with the researcher as well.  
Data collection. 
 Children who assent to participate in the study, whose parents give 
consent for participation, and who meet inclusion criteria will be participants in this 
study. Once informed consent and assent are obtained, the parent or guardian of the child 
will schedule an appointment with the principal investigator for the child to participate in 
a neuropsychological evaluation. Children in the survivorship group who are due for their 
initial neuropsychological evaluation upon entering survivorship or those who are due for 
a neuropsychological re-evaluation will take part in the full neuropsychological 
evaluation given as part of their routine clinical care. Control participants and those 
survivors not due for evaluation or re-evaluation will be administered a short 
neuropsychological battery comprised only of the measures being used as part of the 
proposed study. All evaluations will take place in a quiet, private room in the Children’s 
Blood and Cancer Center (CBCC) in the Specially for Children building at Dell 
Children’s Medical Center in Austin, Texas. The child will engage in a one-on-one 
neuropsychological evaluation with the principal investigator for approximately 90 
minutes (research-only battery) or 330 minutes (full battery) while their parent/guardian 
fills out parent forms (BRIEF, BASC, FAD) in a waiting room. The child will be allowed 
to take breaks as needed during the testing session.  
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Data Analysis and Expected Results 
The purpose of this study is to examine the relationship between family 
functioning and concurrent neurocognitive functioning among survivors of ALL treated 
with chemotherapy as compared to a group of healthy controls. Data will be analyzed 
using a multiple regression analysis. 
Preliminary analyses. 
 Two power analyses were conducted using G*Power software to 
determine the number of participants needed to detect a significant effect (Faul, 
Erdfelder, Buchner, & Lang, 2009). A power analysis for detecting a significant R2 
change requires 55 participants to obtain a moderate effect size (f2 = .15) at the level of 
power of .80 and an alpha of .05 with one independent variable. Because the proposed 
study requires separate regression analyses for the ALL group and the control group, a 
total of 110 participants would be needed. In addition, a power analysis for detecting an 
overall significant R2 deviation from zero with four predictor variables was conducted, in 
accordance with research convention. For four predictor variables, 85 subjects per 
analysis are needed to obtain a moderate effect size (f2 = .15) at the level of power of .80 
and with an alpha of .05. Therefore, 170 total participants are needed. 
Descriptive statistics, including means, standard deviations, ranges, and minimum 
and maximum values, will be computed and analyzed for each variable. Variables will 
also be checked for normality and data will be checked for outliers. Linearity will be 
determined based on scatterplots and normal distribution of residuals will be confirmed 
using a residual and predicted value plot. Data will also be tested for multicollinearlity.  
Tests of research questions. 
Sequential, or hierarchical, multiple regression analyses will be conducted to 
examine the relationship between family functioning and neurocognitive functioning, 
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controlling for age at diagnosis and time since diagnosis within the ALL group and for 
gender and SES in both control and ALL groups (Huck, 2008). Data for the ALL group 
and the control group will be examined using separate analyses. Using a sequential 
regression, the control variables will be entered first. For the experimental group, these 
are: age at diagnosis, gender, time since diagnosis, and SES; for the control group they 
are age, gender, and SES. These will be followed by family functioning as a predictor 
variable for the neurocognitive outcome measures. The p-value associated with the 
change in R2 will be examined to determine if family functioning explains a significant 
amount of variance in neurocognitive outcome, even after controlling for demographic 
and treatment-related variables. A change in R2 associated with an alpha of less than .05 
will be considered significant.  
Hypothesis 1. 
Family functioning is expected to explain a significant amount of variance in 
performance on a task of selective attention, above and beyond that accounted for by 
demographic and treatment-related variables in the ALL group. In the control group, 
family functioning is not expected to account for a significant amount of additional 
variance in performance on a task of selective attention beyond that accounted for by 
demographic variables. 
Family functioning is expected to explain a significant amount of variance in 
performance on a task of divided attention, above and beyond that accounted for by 
demographic and treatment-related variables in the ALL group. In the control group, 
family functioning is not expected to account for a significant amount of additional 
variance in performance on a task of divided attention beyond that accounted for by 
demographic variables. 
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Family functioning is expected to explain a significant amount of variance in 
performance on a task of sustained attention, above and beyond that accounted for by 
demographic and treatment-related variables in the ALL group. In the control group, 
family functioning is not expected to account for a significant amount of additional 
variance in performance on a task of sustained attention beyond that accounted for by 
demographic variables. 
Family functioning is expected to explain a significant amount of variance in 
performance on a task of switching attention, above and beyond that accounted for by 
demographic and treatment-related variables in the ALL group. In the control group, 
family functioning is not expected to account for a significant amount of additional 
variance in performance on a task of switching attention beyond that accounted for by 
demographic variables. 
Family functioning is expected to explain a significant amount of variance in 
scores on parent ratings of attention, above and beyond that accounted for by 
demographic and treatment-related variables in the ALL group. In the control group, 
family functioning is not expected to account for a significant amount of additional 
variance in scores on parent ratings of attention beyond that accounted for by 
demographic variables. 
Hypothesis 2. 
Family functioning is expected to explain a significant amount of variance in 
performance on a task of cognitive flexibility (working memory), above and beyond that 
accounted for by demographic and treatment-related variables in the ALL group. In the 
control group, family functioning is not expected to account for a significant amount of 
additional variance in performance on a task of cognitive flexibility (working 
memory)beyond that accounted for by demographic variables. 
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Family functioning is expected to explain a significant amount of variance in 
performance on a task of goal setting (planning), above and beyond that accounted for by 
demographic and treatment-related variables in the ALL group. In the control group, 
family functioning is not expected to account for a significant amount of additional 
variance in performance on a task of goal setting (planning) beyond that accounted for by 
demographic variables. 
Family functioning is expected to explain a significant amount of variance in 
performance on a task of attentional control (inhibition), above and beyond that 
accounted for by demographic and treatment-related variables in the ALL group. In the 
control group, family functioning is not expected to account for a significant amount of 
additional variance in performance on a task of attentional control (inhibition) beyond 
that accounted for by demographic variables. 
Family functioning is expected to explain a significant amount of variance in 
performance on a task of information processing (processing speed), above and beyond 
that accounted for by demographic and treatment-related variables in the ALL group. In 
the control group, family functioning is not expected to account for a significant amount 
of additional variance in performance on a task of information processing (processing 
speed) beyond that accounted for by demographic variables. 
Family functioning is expected to explain a significant amount of variance in 
scores on parent ratings of executive functioning, above and beyond that accounted for by 
demographic and treatment-related variables in the ALL group. In the control group, 
family functioning is not expected to account for a significant amount of additional 
variance in scores on parent ratings of executive functioning beyond that accounted for 
by demographic variables. 
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Chapter Four: Discussion 
Limitations 
The proposed study has several limitations. First of all, the measure of family 
functioning that is proposed is not specific to the ALL population. As such, it may be 
inadequate to capture the experiences of this population. However, it has a long tradition 
of use in chronically ill populations. Secondly, the sample included in the study might be 
biased towards those children and families who have the means and ability to travel to the 
hospital for testing. As such, the socioeconomic status of participants might not be truly 
representative of the ALL population as a whole. In addition, the proposed study, being 
cross-sectional as opposed to longitudinal, does not follow children from diagnosis 
through survivorship. This, as well as the lack of random assignment, precludes the 
ability to infer causation from the results.  Furthermore, there is the potential for children 
who have received previous evaluations to demonstrate practice effects on 
neuropsychological testing. Since more of the experimental than control participants will 
be likely to have had previous neuropsychological testing, this could confound the results 
of the analyses.  
The proposed study is also limited by the inclusion of only one family member’s 
perspective of family functioning. Ideally, the FAD would have been completed by each 
member of every family participating in the study and a family mean would have been 
calculated, per the recommendation of the developers of the FAD (Alderfer et al., 2009). 
However, this was deemed to be impractical in the current proposed study, as it would 
have limited the sample to only those children able to complete the FAD (i.e., over the 
age of 12 years). Furthermore, differences in family constellations could have introduced 
additional complexities in the comparison of functioning between families, as the number 
of people rating family functioning would have varied based on the number of people in 
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each family. Finally, it is limited by the lack of inclusion of an interview-based measure 
of family functioning. Within the field of family assessment, it is considered ideal to 
obtain both “insider” and “outsider” views of the family’s functioning (Carlson, 2003). 
“Insider” views are those reported by the family members themselves, such as on self-
report measures like the FAD. “Outsider” views are those of clinicians or other observers 
of the family, and may be obtained via structured interview of the family or a clinical 
rating scale. Inclusion of such a measure in the proposed study was considered, but it was 
deemed impractical to require this additional time and energy from participants, 
especially those in the control group.  
Summary and Implications 
The proposed study seeks to fill a gap in the literature on the neurocognitive late 
effects of acute lymphoblastic leukemia by investigating the moderating effect of family 
functioning on attention and executive functioning in survivors of ALL treated with 
chemotherapy. It is expected that positive family functioning will serve as a protective 
factor against late effects in these domains of neurocognitive functioning for ALL 
survivors. If so, this would have important implications for the survivors and their 
families. Such findings would inform efforts to design interventions for this population. If 
it is found that family functioning moderates neurocognitive outcomes for survivors of 
pediatric ALL, then survivors from families with lower levels of functioning could be 
identified early through screening measures and their families could receive targeted 
interventions aimed at improving family functioning and thus survivor outcomes. In the 
modern age of managed care and cost cutting measures, empirically supported 
interventions are necessary. The proposed study could potentially add to the empirical 
base in support of family-level intervention within the ALL population.  
 58 
Future research could also expand upon the current proposed study by 
investigating the bidirectional interactions between family functioning and 
neurocognitive functioning in determining quality of life among survivors of pediatric 
ALL and their families. The proposed study examines the relationship between family 
functioning and neurocognitive functioning in only one direction, but it is likely that the 
relationship between these two variables is more complex than the current model would 
suggest. Specifically, the neurocognitive functioning of the survivor may also impact the 
functioning of the family, and both of these factors could in turn influence the quality of 
life of survivors and their families. A model of survivorship based upon this reciprocal 
relationship between the survivor and their family has been proposed by other researchers 
and evidence has been found to support it in the pediatric brain tumor population 
(Hocking et al., 2011; Peterson & Drotar, 2006). As the relationship between family 
functioning and neurocognitive functioning among survivors of ALL has never been 
investigated, it was beyond the scope of this proposed study to investigate the more 
sophisticated model of survivorship proposed by Peterson and Drotar. However, the 
expected results from this proposed study would give support to the need to investigate 
the applicability of this model to the ALL population.  
This study has the potential to be the first step in a rich and meaningful line of 
research focused on family functioning, neurocognitive functioning, and quality of life 
among survivors of pediatric ALL. Such research is crucial if we are to fulfill the goal, 
described by Bisen-Hersh et al. (2011), of decreasing the late effects of cancer treatment 
so that eventually a child’s fight with cancer will end upon the achievement of remission 
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